Medicines are usually designed for adults with the dose adjusted for children or the elderly.  We believe each of these populations have specific needs that are not met by current treatment options which have the potential to cause unintended harm.  

Children are not small adults.  With many products not tested in children, off-label prescribing leads to the guessing of appropriate dosages and potential adverse effects, with difficult or unpleasant treatment regimens an issue.  It is essential that age-appropriate clinical development plans are undertaken.

For geriatric patients and people with chronic illnesses, adherence is a major concern due to physical difficulties such as swallowing or fear of injection. Declining mental capacity leading to forgetting to take treatment or losing track of time, which are exacerbated by a lack of monitoring, financial constraints, mobility and complicated instructions can also contribute significantly to poor adherence.These patients need treatments that are easy to take and adjusted for their physiology in a simple regimen.